SCHEMBL6947657

SCHEMBL6947657

Cc1nc(NCCCCO)c([N+](=O)[O-])c(N2CCc3ccccc3CC2)n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN2D O15399 2/20 0.39
GRIN3B O60391 2/20 0.39
CHRM1 P11229 2/20 0.39
ADRA1D P25100 2/20 0.39
ADRA1A P35348 2/20 0.39
ADRA1B P35368 2/20 0.39
GRIN1 Q05586 2/20 0.39
GRIN2A Q12879 2/20 0.39
GRIN2B Q13224 2/20 0.39
GRIN2C Q14957 2/20 0.39
GRIN3A Q8TCU5 2/20 0.39
MAPT P10636 6/20 0.39
CDK5 Q00535 2/20 0.39
CDK5R1 Q15078 2/20 0.39
POLB P06746 4/20 0.38
KMT2A Q03164 4/20 0.38
MEN1 O00255 3/20 0.38
GPR55 Q9Y2T6 1/20 0.37
ALDH1A1 P00352 3/20 0.36
LMNA P02545 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6945708 0.98 GRIN2D (0.39) GRIN2DGRIN3BCHRM1ADRA1DADRA1A
SCHEMBL6949237 0.85 ADORA1 (0.46) MAPTPOLBKMT2AMEN1ALDH1A1
SCHEMBL6949324 0.85 KDM4E (0.52) MAPTPOLBALDH1A1LMNAKDM4E
SCHEMBL6949344 0.83 ALDH1A1 (0.52) MAPTPOLBKMT2AMEN1ALDH1A1
SCHEMBL6949472 0.80 MGMT (0.42) MAPTPOLBKMT2AMEN1GPR55
SCHEMBL6948575 0.80 MGMT (0.42) MAPTPOLBKMT2AMEN1GPR55
SCHEMBL6949469 0.78 POLB (0.43) MAPTPOLBKMT2AMEN1GPR55
SCHEMBL6947517 0.78 MEN1 (0.44) MAPTPOLBKMT2AMEN1GPR55
SCHEMBL6951003 0.77 MGMT (0.42) MAPTPOLBKMT2AMEN1GPR55
SCHEMBL6949181 0.76 TSHR (0.43) MAPTPOLBKMT2AMEN1GPR55

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1074549-B1 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors HOFFMANN LA ROCHE (CH) 2003-11-19 EP disclosed
US-6218385-B1 FOR THERAPY OR PROPHYLAXIS OF ACUTE AND/OR CHRONIC NEUROLOGICAL DISORDERS SUCH AS EPILEPSY, STROKE, CHRONIC AND ACUTE PAIN, PSYCHOSIS, SCHIZOPHRENIA, ALZHEIMER'S DISEASE, COGNITIVE DISORDERS AND MEMORY DEFICITS HOFFMANN-LA ROCHE INC. 2001-04-17 US disclosed
EP-1074549-A2 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors F. HOFFMANN-LA ROCHE AG (CH) 2001-02-07 EP disclosed